Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
prilagoditve odmerka med zdravljenjem nedrobnoceličnega pljučnega raka:
dose adjustments during treatment of non-small cell lung cancer:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
zdravilo avastin uporabljamo tudi za zdravljenje napredovalega nedrobnoceličnega raka pljuč.
avastin is also used for the treatment of advanced non-small cell lung cancer.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
napredovalega ali metastatskega nedrobnoceličnega pljučnega raka, ki ni prizadel skvamoznih celic.
advanced or metastatic ‘ non-small cell’ lung cancer that is not affecting the ‘ squamous’ cells.
Last Update: 2012-04-11
Usage Frequency: 1
Quality:
prva linija zdravljenja neskvamoznega nedrobnoceličnega raka pljuč v kombinaciji s kemoterapijo na osnovi platine
first-line treatment of non-squamous nsclc in combination with platinum-based chemotherapy
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pri pediatrični populaciji se pemetrekseda ne uporablja za zdravljenje malignega plevralnega mezotelioma in nedrobnoceličnega karcinoma pljuč.
there is no relevant use of pemetrexed in the paediatric population in malignant pleural mesothelioma and non-small cell lung cancer.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
afatinib z zaviranjem teh beljakovin pomaga nadzorovati delitev celic in posledično upočasni rast in širjenje nedrobnoceličnega pljučnega raka.
by blocking these proteins, afatinib helps to control cell division and thereby slows down the growth and spread of the non-small cell lung cancer.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vsi bolniki so imeli postavljeno diagnozo lokalno napredovalega ali metastatskega nedrobnoceličnega karcinoma pljuč ter so v preteklosti prejemali kemoterapijo.
all patients were diagnosed with locally advanced or metastatic non-small cell lung cancer and received prior chemotherapy.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
pred začetkom zdravljenja z zdravilom zykadia je treba pri bolniku potrditi alk-pozitiven status nedrobnoceličnega pljučnega raka.
alk-positive nsclc status should be established prior to initiation of zykadia therapy.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
v eno glavno študijo neskvamoznega nedrobnoceličnega pljučnega raka je bilo vključenih 582 bolnikov, pri katerih je bolezen kljub prejšnjim zdravljenjem napredovala.
for non-squamous nsclc, one main study involved 582 patients whose disease had progressed despite previous treatments.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
učinkovitost alimte skupaj s cisisplatinom proti gemcitabinu skupaj s cisplatinom pri prvem izboru nedrobnoceličnega carcinoma pljuč – nz populacija in histološke podskupine
itt population
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
pri bolnikih z določenimi podtipi nedrobnoceličnega pljučnega raka z aktivirajočimi mutacijami gena egfr so v študiji pri 152 bolnikih primerjali zdravilo avastin skupaj z erlotinibom z uporabo zgolj erlotiniba.
in patients with a certain subtype of non-small cell lung cancer with activating mutations in the egfr gene, a study in 152 patients compared avastin plus erlotinib with erlotinib alone.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
docefrez v kombinaciji s cisplatinom je indiciran za zdravljenje neresektabilnega, lokalno napredovalega ali metastatskega nedrobnoceličnega pljučnega raka pri bolnikih, ki zaradi te bolezni še niso dobivali kemoterapije.
docetaxel in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small cell lung cancer, in patients who have not previously received chemotherapy for this condition.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pri zdravljenju raka dojke in nedrobnoceličnega pljučnega raka lahko 3-dnevna premedikacija s peroralnim kortikosteroidom, npr. deksametazonom 16 mg na dan (npr.
for breast and non-small cell lung cancers, premedication consisting of an oral corticosteroid, such as dexamethasone 16 mg per day (e.g.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
zdravilo abraxane v kombinaciji s karboplatinom je indicirano kot zdravilo prvega izbora za zdravljenje nedrobnoceličnega pljučnega raka pri odraslih bolnikih, ki niso primerni za operativno zdravljenje in/ali zdravljenje z obsevanjem.
abraxane in combination with carboplatin is indicated for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pri zdravljenju raka dojke, nedrobnoceličnega pljučnega raka, raka želodca ter raka glave in vratu lahko kot premedikacijo dajemo peroralne kortikosteroide, kot je deksametazon 16 mg na dan (npr.
for breast, non-small cell lung, gastric, and head and neck cancers, premedication consisting of an oral corticosteroid, such as dexamethasone 16 mg per day (e.g.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
3 vključno s smrtnimi primeri pri bolnikih, ki so prejemali zdravilo tarceva za zdravljenje nedrobnoceličnega raka pljuč ali drugih napredovalih solidnih tumorjev (glejte poglavje 4.4).
3 including fatalities, in patients receiving tarceva for treatment of nsclc or other advanced solid tumours (see section 4.4).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
namenjeno je odraslim bolnikom, ki imajo določeno vrsto nedrobnoceličnega pljučnega raka (adenokarcinom) in so se predhodno že zdravili z drugim zdravilom proti raku, a je začel tumor ponovno rasti.
it is for adult patients whose nsclc is of a certain type (“adenocarcinoma”) and who had already received one treatment with another medicine to treat this cancer but whose tumour started to grow again.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ti podatki o varnosti predstavljajo celoten nabor podatkov o 682 bolnikih z relapsom pljučnega raka, ki so dobili 2536 ciklusov monoterapije s peroralnim topotekanom (275 bolnikov z relapsom drobnoceličnega pljučnega raka in 407 bolnikov z relapsom nedrobnoceličnega pljučnega raka).
safety data are presented based on an integrated data set of 682 patients with relapsed lung cancer administered 2536 courses of oral topotecan monotherapy (275 patients with relapsed sclc and 407 with relapsed non-sclc).
Last Update: 2017-04-26
Usage Frequency: 1
Quality: